Literature DB >> 18360788

Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity.

Noha A Irani-Hakime1, Farid Stephan, Raghid Kreidy, Isabelle Jureidini, Wassim Y Almawi.   

Abstract

Livedoid vasculopathy (LV) is an occlusive thrombotic disease of lower extremities. A 34-year-old woman presented with 4-year history of recurrent necrotic and painful lesions with violaceous and purpuric border on both legs. Initial treatment with hydroxychloroquine, dapsone and prednisone were unsuccessful. Skin biopsy showed inflammatory infiltrate with epidermal necrosis. Prothrombin G20210A and factor V-Leiden heterozygosity, and MTHFR C677T homozygosity with hyperhomocysteinemia were confirmed. LV diagnosis was made; acetylsalicylic acid, folic acid, vitamin B12, and prednisone treatement resulted in complete healing. This is the first report on coexistence of prothrombin G20210A, factor V-Leiden, and homozygous MTHFR C677T with hyperhomocysteinemia in LV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18360788     DOI: 10.1007/s11239-008-0214-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  24 in total

1.  Homocysteinemia and livedoid vasculitis.

Authors:  G E Gibson; H Li; M R Pittelkow
Journal:  J Am Acad Dermatol       Date:  1999-02       Impact factor: 11.527

2.  Treatment of livedoid vasculopathy with short-cycle intravenous immunoglobulins.

Authors:  Gerard Pitarch; Mercedes Rodríguez-Serna; Arantxa Torrijos; Vicente Oliver; José Miguel Fortea
Journal:  Acta Derm Venereol       Date:  2005       Impact factor: 4.437

Review 3.  Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation.

Authors:  Kenneth T Calamia; Maria Balabanova; Charles Perniciaro; John S Walsh
Journal:  J Am Acad Dermatol       Date:  2002-01       Impact factor: 11.527

4.  Livedo vasculitis (the vasculitis of atrophie blanche). Immunohistopathologic study.

Authors:  A L Schroeter; J L Diaz-Perez; R K Winkelmann; R E Jordan
Journal:  Arch Dermatol       Date:  1975-02

5.  Livedoid vasculitis: a manifestation of the antiphospholipid syndrome?

Authors:  K M Acland; A Darvay; S H Wakelin; R Russell-Jones
Journal:  Br J Dermatol       Date:  1999-01       Impact factor: 9.302

6.  Livedoid vasculopathy in a patient with factor V mutation (Leiden).

Authors:  T Biedermann; M J Flaig; C A Sander
Journal:  J Cutan Pathol       Date:  2000-09       Impact factor: 1.587

7.  Livedo vasculitis. Segmental hyalinizing vasculitis of the dermis.

Authors:  J W Bard; R K Winkelmann
Journal:  Arch Dermatol       Date:  1967-11

8.  [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies].

Authors:  A Grasland; B Crickx; M Blanc; J Pouchot; P Vinceneux
Journal:  Ann Med Interne (Paris)       Date:  2000-09

9.  [Liveoid vasculopathy with combined thrombophilia: efficacy of iloprost].

Authors:  N Magy; M P Algros; E Racadot; H Gil; B Kantelip; J L Dupond
Journal:  Rev Med Interne       Date:  2002-06       Impact factor: 0.728

10.  Tissue plasminogen activator for treatment of livedoid vasculitis.

Authors:  K L Klein; M R Pittelkow
Journal:  Mayo Clin Proc       Date:  1992-10       Impact factor: 7.616

View more
  4 in total

1.  Livedoid vasculopathy in a patient with lupus anticoagulant and MTHFR mutation: treatment with low-molecular-weight heparin.

Authors:  Jihane Abou Rahal; Rim S Ishak; Zaher K Otrock; Abdul-Ghani Kibbi; Ali T Taher
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

Review 2.  Livedoid vasculopathy: A multidisciplinary clinical approach to diagnosis and management.

Authors:  Asli Bilgic; Salih Ozcobanoglu; Burcin Cansu Bozca; Erkan Alpsoy
Journal:  Int J Womens Dermatol       Date:  2021-09-02

3.  Painless Livedoid Vasculopathy in a Patient with G20210A Prothrombin Gene Mutation.

Authors:  Aibek E Mirrakhimov; Erwin Velasquez Kho; Alaa Ali
Journal:  Case Rep Med       Date:  2012-09-05

4.  Refractory ulcerations associated with livedoid vasculopathy successfully treated with tofacitinib.

Authors:  Ertao Jia; Guangyao Yan; Min Xiao; Hongling Geng; Jiaxin Wei; Jianyong Zhang
Journal:  Dermatol Ther       Date:  2020-11-16       Impact factor: 2.851

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.